Drug Shortage Report for MYLAN-TOLTERODINE ER

Last updated on 2022-02-15 History
Report ID 25895
Drug Identification Number 02404192
Brand name MYLAN-TOLTERODINE ER
Common or Proper name TOLTERODINE ER
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOLTERODINE TARTRATE
Strength(s) 4MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 30BT, 100BT
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-11-16
Actual start date 2017-11-13
Estimated end date Unknown
Actual end date 2022-02-14
Shortage status Resolved
Updated date 2022-02-15
Company comments Last lot 3082332, Expiry November-30-2018
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2022-02-15 French Compare
v30 2022-02-15 English Compare
v29 2020-01-06 French Compare
v28 2020-01-06 English Compare
v27 2019-02-21 French Compare
v26 2019-02-21 English Compare
v25 2018-11-06 French Compare
v24 2018-11-06 English Compare
v23 2018-10-03 French Compare
v22 2018-10-03 English Compare
v21 2018-08-28 French Compare
v20 2018-08-28 English Compare
v19 2018-07-25 French Compare
v18 2018-07-25 English Compare
v17 2018-05-23 French Compare
v16 2018-05-23 English Compare
v15 2018-05-18 French Compare
v14 2018-05-18 English Compare
v13 2018-05-01 French Compare
v12 2018-05-01 English Compare

Showing 1 to 20 of 31